Lu Xiangyi’s centrifuge boosts vaccine production; 29 L800R ultra-large-capacity refrigerated centrifuges delivered in bulk to vaccine companies.

　　On July 26, 2024, Lu Xiangyi Centrifuge received exciting news: the latest batch of 29 L800R ultra-large-capacity refrigerated centrifuges—now in full production—have been fully assembled and are ready to be shipped to a well-known vaccine manufacturer in China. This announcement marks another significant achievement for Lu Xiangyi Centrifuge in the high-end centrifuge manufacturing sector and injects new technological momentum into China’s vaccine research and development and production efforts.

　　This batch of L800R ultra-large-capacity refrigerated centrifuges represents the masterful craftsmanship of Luxiangyi Centrifuge. Each unit is equipped with six 2000ml stainless steel centrifuge bottles, fully demonstrating its exceptional processing capacity and professional quality. These high-tech devices are neatly arranged, resembling a train poised for departure—ready to play a pivotal role in vaccine research and development as well as production.

　　The workers are meticulously carrying out the final inspections and loading operations. Every single one of their movements reveals their deep passion for the products and their unwavering commitment to quality. The smooth delivery of this batch of equipment not only serves as a comprehensive test of Luxiangyi’s R&D and production capabilities in centrifuges, but also represents a powerful boost to the company’s industry standing and market influence.

　　It is foreseeable that the commissioning of this batch of L800R ultra-large-capacity refrigerated centrifuges will greatly enhance the R&D and production efficiency of vaccine manufacturers, providing strong support for the rapid development of China’s vaccine industry. At the same time, this will further promote Lu Xiangyi Centrifuge’s ongoing innovation and development in the high-end centrifuge manufacturing sector, bringing more advanced and efficient centrifuge solutions to an even wider range of industries and fields.

　　Against the backdrop of continuously growing global demand for vaccine research and development and production, Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. once again demonstrated its prominent position in the industry by successfully delivering 29 L800R ultra-large-capacity refrigerated centrifuges in bulk to a well-known domestic vaccine manufacturer. This delivery not only highlights Luxiangyi’s deep-rooted expertise in the field of biopharmaceutical equipment but also provides a solid guarantee for the efficiency and quality of vaccine production.

　　The L800R ultra-large-capacity refrigerated centrifuge, a star product of Luxiangyi Centrifuges, has earned widespread market recognition thanks to its outstanding performance and advanced technology. This model is standardly equipped with six 2,000 ml stainless steel centrifuge bottles, significantly boosting its single-run processing capacity and effectively meeting the demand for handling large volumes of samples in vaccine production. At the same time, paired with an advanced PLC control system, the L800R has achieved a comprehensive intelligent upgrade—from operation to data management.

　　The PLC control system software boasts a wealth of outstanding features:

　　Full-touch industrial control tablet: Offers an intuitive and efficient user interface, combined with large-capacity storage memory, ensuring smooth and uninterrupted operation.

　　PID dynamic regulation: Precisely controls rotational speed and temperature, ensuring highly stable and reproducible experimental conditions.

　　Multi-level password management: Flexibly set administrative permissions to ensure the security and confidentiality of experimental data.

　　Automatic logout with time settings: Enhances the convenience and security of device usage.

　　Multiple alarm and protection functions: Provide all-round assurance for stable equipment operation and reduce the risk of failures.

　　Parameter Settings and Recipe Management: Supports multi-stage centrifugation functionality to meet various experimental needs while simplifying the operational workflow.

　　Long-term data storage: Centrifuge data, curves, and alarm records can be stored for up to over 10 years, facilitating easy tracking and analysis.

　　Audit Trail and Data Networking: Data is transmitted via an RJ45 network port to SCADA and MES systems, complying with the latest GMP standards as well as FDA 21 CFR, Part 11 requirements for electronic records and electronic signatures, thereby providing robust support for quality traceability in vaccine production.

　　This delivery marks Lu Xiangyi Centrifuge The deepened collaboration between technology companies and vaccine manufacturers has entered a new phase. Together, the two sides will move forward hand in hand, jointly driving innovation and development in vaccine research and manufacturing technologies. Lu Xiangyi Centrifuge will continue to uphold its corporate philosophy of “Innovation, Quality, and Service,” contributing more high-quality, high-performance laboratory equipment to the global biopharmaceutical industry and helping the cause of human health flourish.